Glucagon like peptide 1 analogue, Liraglutide, reduces adipose insulin resistance and hepatic de novo lipogenesis in Nonalcoholic Steatohepatitis: Sub-study results of a phase II randomised-control clinical trial
Main Authors: | , , , , , , , , , , , |
---|---|
Format: | Conference item |
Published: |
2013
|